FANCD2 associated with sporadic breast cancer risk

被引:35
作者
Barroso, E.
Milne, R. L.
Fernandez, L. P.
Zamora, P.
Arias, J. I.
Benitez, J.
Ribas, G. [1 ]
机构
[1] Spanish Natl Canc Ctr, Human Genet Grp, Human Canc Genet Programme, E-28029 Madrid, Spain
[2] Spanish Natl Canc Ctr, Natl Genotyping Ctr CeGen, Human Canc Genet Programme, E-28029 Madrid, Spain
[3] Hosp La Paz, Dept Oncol, Madrid, Spain
[4] Monte Naranco Hosp, Surg Unit, Oviedo, Spain
关键词
D O I
10.1093/carcin/bgl062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several components of the Fanconi anaemia (FA) family of proteins allow the formation of the DNA repair complex foci formed by proteins such as BRCA1/2 and RAD51. Because the genes that participate in the DNA repair pathway have been described as low-penetrance breast cancer susceptibility genes, we postulated that variants in FA genes could also be associated with sporadic breast cancer risk. We studied seven SNPs in FANCA, FANCL and FANCD2 in a total of 897 consecutive and non-related sporadic breast cancer cases and 1033 unaffected controls from the Spanish population. We observed a statistically significant association with sporadic breast cancer for the variant rs2272125 (L1366L) located on FANCD2 (OR per allele = 1.35; 95% C.I. 1.09-1.67; P = 0.005). Both haplotype and diplotype analyses confirmed this association, where one haplotype and pooled diplotypes carrying it were associated with more than 4-fold risk (P = 0.007 and P = 0.006, respectively). Screening for potential causal variants in FANCD2 was performed, detecting one in the putative promoter region, which is located in a phylogenetically conserved motif with consensus binding sites for some transcriptional factors, suggesting a functional implication. Our data indicate that a relationship between FANCD2 and sporadic breast cancer risk may exist.
引用
收藏
页码:1930 / 1937
页数:8
相关论文
共 80 条
[1]   Cancer in Fanconi anemia [J].
Alter, BP ;
Greene, MH ;
Velazquez, I ;
Rosenberg, PS .
BLOOD, 2003, 101 (05) :2072-2073
[2]   ATR couples FANCD2 monoubiquitination to the DNA-damage response [J].
Andreassen, PR ;
D'Andrea, AD ;
Taniguchi, T .
GENES & DEVELOPMENT, 2004, 18 (16) :1958-1963
[3]  
[Anonymous], 2003, Stata Statistical Software
[4]   Polygenic inheritance of breast cancer: Implications for design of association studies [J].
Antoniou, AC ;
Easton, DF .
GENETIC EPIDEMIOLOGY, 2003, 25 (03) :190-202
[5]   Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Ponder, BAJ ;
Easton, D .
GENETIC EPIDEMIOLOGY, 2001, 21 (01) :1-18
[6]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[7]   The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair [J].
Bridge, WL ;
Vandenberg, CJ ;
Franklin, RJ ;
Hiom, K .
NATURE GENETICS, 2005, 37 (09) :953-957
[8]   Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints [J].
Cliby, WA ;
Roberts, CJ ;
Cimprich, KA ;
Stringer, CM ;
Lamb, JR ;
Schreiber, SL ;
Friend, SH .
EMBO JOURNAL, 1998, 17 (01) :159-169
[9]  
Colleu-Durel S, 2001, ONCOL REP, V8, P1001
[10]   A multigene test for the risk of sporadic breast carcinoma [J].
Comings, DE ;
Gade-Andavolu, R ;
Cone, LA ;
Muhleman, D ;
MacMurray, JP .
CANCER, 2003, 97 (09) :2160-2170